Cardiovascular Outcomes in Patients on Hemodialysis following Drug-Eluting versus Bare-Metal Coronary Stents

Cardiovascular Outcomes in Patients on Hemodialysis following Drug-Eluting versus Bare-Metal Coronary Stents

Aim. This study sought to compare short- and long-term outcomes of drug-eluting stents (DESs) versus bare-metal stents (BMSs) implantation in patients with end-stage renal disease on hemodialysis (ESRD-HD) undergoing percutaneous coronary intervention (PCI). Methods. Adult patients with ESRD-HD who...

Full description

Saved in:

Bibliographic Details
Main Authors:	Amir F. Mohani, Srikanth Penumetsa, Amin Daoulah, Gregory Giugliano, Amir Lotfi
Format:	Article
Language:	English
Published:	Wiley 2018-01-01
Series:	Cardiology Research and Practice
Online Access:	http://dx.doi.org/10.1155/2018/4934982
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Very Late Bare Metal Stent Thrombosis
by: Mariana Soto Herrera, et al.
Published: (2013-01-01)

Acute Coronary Syndrome after 17 Years of Bare Metal Stent Implantation: “Very” Very Late Stent Thrombosis
by: Raghavendra Rao K, et al.
Published: (2020-01-01)

An Infected, Noncoronary, Bare Metal Stent Presenting as a Right Groin Abscess
by: Madiha Khan, et al.
Published: (2023-01-01)

Stent Fracture after Everolimus-Eluting Stent Implantation
by: Ali S. Almasood, et al.
Published: (2011-01-01)

Effect of rapamycin-eluting stents on in-stent restenosis and early inflammatory response in coronary artery narrowing animal models
by: Jianbing Zhang, et al.
Published: (2025-01-01)

Drug-Coated versus Uncoated Balloon for Side Branch Protection in Coronary Bifurcation Lesions Treated with Provisional Stenting Using Drug-Eluting Stents: A Meta-analysis
by: Zhi-Ming Jiang, et al.
Published: (2022-01-01)

Everolimus-Eluting Biodegradable Abluminal Coating Stent versus Durable Conformal Coating Stent: Termination of the Inflammatory Response Associated with Neointimal Healing in a Porcine Coronary Model
by: Masayuki Mori, et al.
Published: (2020-01-01)

Impact of Obstructive Sleep Apnea on In-Stent Restenosis in Coronary Heart Disease Patients after Elective Drug-Eluting Stenting
by: Wenjie Yang, et al.
Published: (2025-01-01)

Angiographic Restenosis in Coronary Bifurcations Treatment with Regular Drug Eluting Stents and Dedicated Bifurcation Drug-Eluting BiOSS Stents: Analysis Based on Randomized POLBOS I and POLBOS II Studies
by: Robert J. Gil, et al.
Published: (2020-01-01)

Catlet scoring system as a new predictor for in-stent restenosis in patients with chronic coronary artery disease undergoing percutaneous coronary intervention with drug-eluting stent
by: Juan Wang, et al.
Published: (2025-01-01)

Advantages and disadvantages of coronary drug-eluting stent: a 23-year journey of randomized clinical trials
by: Alfredo E. Rodriguez, et al.
Published: (2024-07-01)

Comparison of biodegradable and durable polymer drug-eluting stents in acute coronary syndrome: a meta-analysis
by: Tingting Wei, et al.
Published: (2022-06-01)

A comparison of drug‐eluting stent and coronary artery bypass grafting in mildly to moderately ischemic heart failure
by: Kun Wang, et al.
Published: (2022-06-01)

Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at a Tertiary Medical Center
by: Nicolas W. Shammas, et al.
Published: (2013-01-01)

Patient Safety Events Related to the Placement of Drug-Eluting Stents
by: Patient Safety Authority
Published: (2023-12-01)

Midterm Clinical Impacts of Biodegradable Polymer Everolimus-Eluting Stents Compared with Durable Polymer Everolimus-Eluting Stents: A 3-Year Propensity-Matched Study
by: Hiroaki Matsuda, et al.
Published: (2020-01-01)

On bare and non-bare temporal names in Romanian
by: Mihaela Tănase-Dogaru
Published: (2022-12-01)

Prognostic Value of Plasma Pentraxin-3 Levels in Patients with Stable Coronary Artery Disease after Drug-Eluting Stent Implantation
by: Liu Haibo, et al.
Published: (2014-01-01)

Benefits and Harms of Extending the Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Drug-Eluting Stents: A Meta-Analysis
by: Chun Shing Kwok, et al.
Published: (2014-01-01)

Safety and efficacy of edoxaban monotherapy after bioabsorbable polymer everolimus-eluting stent implantation in a human-like coronary atherosclerotic porcine model
by: Daisuke Kitano, et al.
Published: (2025-03-01)

On barely continuous functions
by: Richard Stephens
Published: (1988-01-01)

Clinical Outcomes from Unselected “Real-World” Patients with Long Coronary Lesion Receiving 40 mm Biodegradable Polymer Coated Sirolimus-Eluting Stent
by: Anurag Polavarapu, et al.
Published: (2015-01-01)

Pioglitazone Attenuates Drug-Eluting Stent-Induced Proinflammatory State in Patients by Blocking Ubiquitination of PPAR
by: Zhongxia Wang, et al.
Published: (2016-01-01)

Effect of high-quality nursing interventions on the quality of life and cardiac index in acute coronary syndrome patients treated with drug-eluting stents: a randomized trial study
by: Zeinab Abdollahifar, et al.
Published: (2025-01-01)

Corrigendum to “Pioglitazone Attenuates Drug-Eluting Stent-Induced Proinflammatory State in Patients by Blocking Ubiquitination of PPAR”
by: Zhongxia Wang, et al.
Published: (2019-01-01)

Modelling chemistry and biology after implantation of a drug-eluting stent. Part Ⅱ: Cell proliferation
by: Adam Peddle, et al.
Published: (2018-09-01)

Modelling chemistry and biology after implantation of a drug-eluting stent. Part Ⅰ: Drug transport
by: Tuoi Vo, et al.
Published: (2017-03-01)

Polymers for Cardiovascular Stent Coatings
by: Anne Strohbach, et al.
Published: (2015-01-01)

Partially Covered Self-Expandable Metal Stents versus Polyethylene Stents for Malignant Biliary Obstruction: A Cost-Effectiveness Analysis
by: Alan N Barkun, et al.
Published: (2015-01-01)

Sirolimus-Eluting Balloon for the Treatment of Coronary Lesions in Complex ACS Patients: The SELFIE Registry
by: Gianluca Caiazzo, et al.
Published: (2020-01-01)

Incidence and Predictors of Outcome in the Treatment of In-Stent Restenosis with Drug-Eluting Balloons, a Real-Life Single-Centre Study
by: Kyle Murnaghan, et al.
Published: (2022-01-01)

Peripheral Artery Disease Intervention: Drug-Coated Balloon vs Drug-Eluting Stent, A Long-Term Comparison
by: Nathan Marzlin, et al.
Published: (2022-01-01)

Low Resolution Limits and Inaccurate Algorithms Decrease Significantly the Value of Late Loss in Current Drug-Eluting Stent Trials
by: Johannes B. Dahm, et al.
Published: (2012-01-01)

Percutaneous Coronary Intervention Complexity and Risk of Adverse Events in relation to High Bleeding Risk among Patients Receiving Drug-Eluting Stents: Insights from a Large Single-Center Cohort Study
by: Hao-Yu Wang, et al.
Published: (2020-01-01)

Safety and Efficacy of Second-Generation Drug-Eluting Stents in Real-World Practice: Insights from the Multicenter Grand-DES Registry
by: You-Jeong Ki, et al.
Published: (2020-01-01)

Clinical Outcomes of Carotid Artery Stenting for Carotid Artery Stenosis in Maintenance Hemodialysis Patients
by: Shuki OKUHARA, et al.
Published: (2025-01-01)

Exploring Bare Ownership Supply of Housing in Urban Environments
by: Maria Rosaria Guarini, et al.
Published: (2025-01-01)

Percutaneous Coronary Intervention Using the DynamX Sirolimus-Eluting Bioadaptor: 12-Month Clinical and Imaging Outcomes
by: Mark Webster, et al.
Published: (2024-01-01)

Efficacy of SMART Stent Placement for Salvage Angioplasty in Hemodialysis Patients with Recurrent Vascular Access Stenosis
by: Shingo Hatakeyama, et al.
Published: (2011-01-01)

Combination of the endoscopic septonasal flap technique and bioabsorbable steroid-eluting stents for repair of congenital choanal atresia in neonates and infants: a retrospective study
by: Peng-peng Wang, et al.
Published: (2021-08-01)